Articles tagged with Obesity
Researchers have developed a new weight loss drug that combines GLP-1 with molecules blocking the NMDA receptor, exploiting its effects on appetite control and neuroplasticity. This approach shows promise for greater weight loss in mice than existing medications.
Researchers at Tokyo University of Science developed menthyl esters with potent anti-inflammatory and anti-obesity effects. The compounds outperformed menthol in inflammatory assays and suppressed genes involved in immune responses. They also inhibited adipogenesis, showing promise for addressing metabolic disorders.
A new UK-based trial found that text messages with financial incentives can help men with obesity lose weight, with an average of 4.8% body weight loss over 12 months. The study, which involved 585 men living with obesity, suggests that text messaging alone may not be as effective in promoting weight loss.
A wireless feedback system is comparable to a similar system with added coaching in achieving meaningful weight loss. The study suggests that technology alone may not produce clinically acceptable weight loss for most individuals, highlighting the need for stepped care with human coach support.
A new study suggests a lower BMI threshold of 27 kg/m² may be more appropriate than the existing WHO BMI threshold (30 kg/m²) for middle-aged and older adults. This could lead to improved health outcomes for millions of older adults, as body fat percentage is a more accurate indicator of obesity.
A new Northwestern University study found that technology alone resulted in worse weight loss compared to a combination of tech and telehealth coaching for obesity treatment. The study suggests that while technology has its benefits, it cannot replace the human touch for meaningful weight loss.
A new study shows that text messaging with financial incentives significantly improves weight loss in men with obesity compared to traditional methods. The intervention combines personalized text messages with cash rewards, resulting in a 5% weight loss threshold, and could be an effective low-cost solution for health services.
Two studies based on the SELECT trial show semaglutide leads to sustained weight loss of 10% body weight and 7cm waist reduction after 4 years, regardless of starting weight or BMI. The medication also delivers cardiovascular benefits, with a lower risk of heart attack, stroke, or death.
A new Italian study has found that people living with obesity often conceal their bodies in WhatsApp profile pictures, indicating potential body dysmorphic disorder. The study suggests that such images could provide valuable insights into patients' psychological states.
A recent analysis of WHI findings indicates that MetS and obesity each have different associations with breast cancer subtypes and mortality risk. Women with higher MetS scores are at a higher risk of poor-prognosis, estrogen receptor-positive, progesterone receptor-negative breast cancers.
The European Association for the Study of Obesity highlights TikTok's potential in addressing childhood obesity. Analysis of Dr Anthos' TikTok account reveals popular videos on obesity medication and stigma combating, with live Q&A sessions generating significant discussion.
A UK survey found that only 13% of respondents would be willing to regularly consume insects, highlighting the need to overcome the 'disgust factor' for entomophagy to become mainstream. The study suggests that incorporating insect flours into processed foods may help reduce disgust and increase consumer acceptance.
Researchers found that Kallistatin expression increases after weight loss in individuals with overweight and obesity. Additionally, human Kallistatin improves hepatic insulin sensitivity in diet-induced obese mice. The study suggests that Kallistatin may be an interesting therapeutic target for people with obesity and type 2 diabetes.
Researchers found that smokers skip meals more often, go longer without eating, and are more likely to snack between meals. They also tend to eat fewer sweet foods, but more fried foods, salt, and sugar than non-smokers.
A Danish study found that patients who tapered off semaglutide slowly and focused on lifestyle changes maintained their weight loss for at least 6 months. Lower doses of the drug were as effective as higher ones, with a tailored approach minimising side-effects.
A randomized trial found that aerobic exercise significantly reduced inflammatory markers in adults with obesity, including IL-6 and IFN-γ levels. Exercise combined with liraglutide treatment showed no additional benefits in reducing inflammation compared to placebo or liraglutide alone.
Food and drink advertisements on videogame livestreaming platforms (VGLSPs) like Twitch are associated with more positive attitudes towards and purchases of unhealthy foods. Researchers call for stronger regulations to protect young viewers from the potential harms of digital food marketing.
Researchers found that men with obesity have increased adipose tissue insulin resistance and higher levels of free fatty acids in the blood. This may partly explain why type 2 diabetes is more common in men. The study suggests that sex differences in adipose tissue insulin sensitivity could be a key factor in this disparity.
A Swedish study found that individuals with large fat cells tend to lose weight over time, while those with small fat cells gain weight. The study suggests that measuring the size of fat cells could be important for weight management later in life.
A Swedish study of people living with obesity found that poor muscle health is associated with a higher risk of an early death. Adverse muscle composition was up to three times more likely to lead to death during the course of the study than those with healthy muscles.
A new endoscopic procedure has been developed to reduce production of ghrelin, a key hunger hormone, by ablating the stomach lining. This process resulted in a 7.7% body weight loss and a 40% reduction in fasting ghrelin levels in a six-month trial involving 10 female patients with obesity.
A new study from Washington State University found that just a few days on a night shift schedule can disrupt protein rhythms related to blood glucose regulation and energy metabolism. This dysregulation may lead to chronic metabolic conditions such as diabetes and obesity.
Researchers have identified a population of mesothelial-like cells in omental adipose tissue that limit fat cell formation, offering new insights into the mechanisms underlying obesity. These cells secrete Insulin-like Growth Factor Binding Protein 2, which inhibits adipogenesis and regulates metabolic behavior.
The American Society for Nutrition's NUTRITION 2024 will bring together thousands of experts to share emerging scientific and policy developments in food, nutrition, and public health. Over 1,600 original research studies will be presented during the meeting.
A Mayo Clinic study found that laparoscopic sleeve gastrectomy can improve the health and eligibility of patients with advanced chronic kidney disease and obesity. The procedure reduced cardiovascular risks, including diabetes and hypertension, and improved access to kidney transplantation.
A study published in PLOS ONE found that combining time-restricted eating with high-intensity functional training improves body composition and cardiometabolic health more than either alone. The research, conducted on inactive women with obesity, showed significant weight loss and favorable changes in lipid and glucose levels.
Researchers have identified a new regulator of eating behavior, the latrophilin 1 receptor, which is linked to obesity. The receptor, primarily studied for its role in synapse formation, was found to be present in brain regions controlling food intake and adipose tissue.
Researchers at Karolinska Institutet have discovered a new class of drugs that block mitochondrial function and reverse diet-induced obesity, fatty liver, and diabetes in mice. The treatment increased fat metabolism, leading to drastic weight loss and restored glucose tolerance.
Researchers from Denmark and Germany found a protein that switches off brown fat shortly after activation, limiting its effectiveness as a treatment for obesity. Blocking this protein could lead to promising strategies for safely activating brown fat and tackling weight loss.
A recent study found that individuals with a rare condition known as growth hormone receptor deficiency (GHRD) have normal or improved levels of cardiovascular disease risk factors compared to their relatives. This suggests that GHRD may actually protect against cardiovascular disease, contrary to previous speculation.
The study reveals that TM4SF19 protein inhibits a pump in lysosomes, impeding macrophage clearance of dead cells. Macrophages lacking TM4SF19 demonstrate enhanced efficacy in clearing dead adipocytes, reducing weight gain and metabolic dysfunction. The findings may open new avenues for treating obesity and related metabolic disorders.
A study of over 7,500 US adults found that higher abdominal obesity, measured by waist circumference-to-height ratio, was associated with a higher risk of fecal incontinence. The researchers suggest that this may be due to increased intra-abdominal pressure and visceral fat-related inflammation.
Atrial fibrillation is more common and deadly among young Americans than previously believed, a new study found. The study of over 67,000 patients under 65 years old showed higher rates of hospitalization, stroke, heart attack, comorbidity, and mortality compared to their peers without Afib.
Researchers investigate the neuroprotective effects of tocotrienols in alleviating obesity-induced cognitive decline. The study found that T3s treatment improved cognitive function and mitigated oxidative stress in mice fed with a high-fat, high-sucrose diet.
The study found that chronic administration of melatonin prevents obesity and reduces visceral obesity by around 3%. Melatonin also enhances weight loss when combined with cold water bathing. The researchers recommend incorporating melatonin, natural light exposure, and physical activity into daily routines to manage obesity.
A new study found that consuming sugary drinks in early childhood increases the risk of obesity later in life. The research tracked 14,000 British children from birth to adulthood and discovered a link between sugar-sweetened drinks and poor diet patterns.
Endoscopic sleeve gastroplasty is a cost-saving option compared to semaglutide for treating class II obesity. A study found that achieving price parity with semaglutide requires a significant discount of at least 3-fold.
Thorsten Hoppe and Jens Brüning received 2.5 million euros in funding from the European Research Council to investigate protein degradation and neural circuits of metabolic control, respectively. Their projects focus on preventing neurodegeneration and developing new drugs for obesity treatment.
A comprehensive Scandinavian study has found no evidence that popular diabetes medications GLP-1 analogues increase the risk of thyroid cancer. The research analysed data from over 145,000 patients treated with these drugs and compared them to other patient groups.
Researchers found that CMS121 reduced body weight gain by 40% and improved glucose and lipid indexes in aging mice. The compound also showed anti-inflammatory effects and increased mitochondrial biogenesis, suggesting potential therapeutic applications for metabolic diseases.
Researchers found that undertaking majority of daily aerobic physical activity in the evening is associated with lower risk of premature death and cardiovascular disease for people with obesity. The study, published in Diabetes Care, suggests that planning physical activity into certain times of the day may help offset some health risks.
A four-component school-based nutritional intervention package improved diet quality among adolescents and their household members, reducing undernutrition and obesity. The study found promising spillover effects into households and communities, highlighting the transformative potential of schools in combating adolescent malnutrition.
Scientists have discovered genetic variants in BSN and APBA1 genes linked to adult-onset obesity, type 2 diabetes, and fatty liver disease. These variants are associated with a significant increase in obesity risk, highlighting a new biological mechanism for the condition.
A study finds that gut microbiota play a key role in obesity development, with distinct differences between men and women. Researchers identified specific bacterial species and metabolites associated with higher BMI, fat mass, and waist circumference in women, but not men.
Studies at the University of Gothenburg found a clear shift in arterial disease risks in diabetes, with decreases in central organ diseases like heart attack and stroke, but increases in peripheral vessel complications. Closer monitoring of long-term blood sugar levels can reduce peripheral arterial disease risk by 30-50%.
A new study from Karolinska Institutet found no increased health risks for mothers or children with weight gain below recommended guidelines for women with obesity classes 1 and 2. In contrast, weight loss was associated with reduced risk of adverse outcomes in women with class 3 obesity.
A new study has found that replacing sugar with artificial and natural sweeteners in foods does not make people hungrier, but may help reduce blood sugar levels. The trial involved 53 adult men and women with overweight or obesity and found no differences in appetite or endocrine responses compared to sugar.
The study found that obesity rates have nearly tripled in adult men and doubled in women since 1990. The prevalence of malnutrition is now the most common form of malnutrition globally, affecting nearly 880 million adults and 160 million children. Obesity can lead to comorbidities like high blood pressure, heart disease, and diabetes.
Individuals at high genetic risk of obesity needed higher daily step counts to reduce obesity risk. Population-based recommendations may underestimate physical activity needed among those at high genetic risk.
Research published in JAMA Network Open found that individuals with higher genetic risk of obesity need to walk more steps per day than those with lower risk to avoid becoming obese. Participants with a higher polygenic risk score required significantly more physical activity, with some needing up to 11,020 steps per day.
Researchers have identified two plant compounds with potential as GLP-1 agonist weight loss pills, derived from common plants and potentially offering fewer side effects than current medications. The discovery was made using high-performance artificial intelligence techniques to analyze over 10,000 compounds.
A new study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes, showing significant weight loss and improved glucose control. Tirzepatide also reduces insulin dose and increases time-in-range on continuous glucose monitoring.
A European randomized controlled trial found that replacing sugar with sweeteners improved weight loss control for at least one year after rapid weight loss in adults. The study also showed greater diet satisfaction and lower cravings for sweet foods among participants who consumed low/no-energy sweetened products.
Researchers have identified the unique nutritional profile of Canadian sea buckthorn berries, which are rich in polyphenols with potential health benefits for cardiovascular protection and anti-inflammatory properties. The study found that geographical factors influence the polyphenolic profile of the berries, making them a promising s...
A study published in Nature Metabolism reveals that the diabetes drug metformin and solid foods increase a hunger-reducing factor called Lac-Phe, while sugary drinks have minimal effect. This discovery could lead to new anti-obesity treatments and help explain why liquid calories drive obesity.
Researchers found obese individuals exhibit distinct walking patterns, characterized by shorter strides and modified ankle muscle activation. This study suggests these differences may increase the risk of falls and musculoskeletal disorders.
Recent medications for Type 2 diabetes and weight loss have positive effects on cardiovascular and kidney health but are not always prescribed or accessible to those who need them. The studies highlight the need to address barriers to access and equity, particularly among Black adults with severe obesity.
Researchers found that Kallistatin expression increases after weight loss, improving hepatic insulin sensitivity in obese mice. This protein may be an interesting therapeutic target for treating obesity and type 2 diabetes.
Researchers at Flinders University have discovered a bedtime nasal spray that can reduce the severity of sleep apnea in people and lower their blood pressure. The study found that the spray, which blocks potassium channels, improved oxygen levels and reduced markers of OSA severity in 7 out of 10 participants.
A new study published in the Journal of the Endocrine Society found significant cardiometabolic improvements in patients who underwent bariatric surgery, including lower blood pressure and cholesterol levels. The study analyzed over 7,800 patients and showed that younger females and whites experienced greater post-surgery cardiometabol...